| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA5078260 | [64Cu]Cu-DOTA-TATE | SUVmax | = | 0.5 | ALA5043880 | ||||||
| 2. | ALA5078260 | [64Cu]Cu-DOTA-TATE | SUVmax | = | 2.7 | ALA5043879 | ||||||
| 3. | ALA5078260 | [64Cu]Cu-DOTA-TATE | SUVmax | < | 1 | ALA5043878 | ||||||
| 4. | ALA5078260 | [64Cu]Cu-DOTA-TATE | SUVmax | = | 1.43 | ALA5043877 | ||||||
| 5. | ALA5078260 | [64Cu]Cu-DOTA-TATE | Activity | 0 | ALA5043876 | Active | ||||||
| 6. | ALA5078260 | [64Cu]Cu-DOTA-TATE | SUV | = | 3 | ALA5043875 | ||||||
| 7. | ALA5078260 | [64Cu]Cu-DOTA-TATE | SUV | = | 6.5 | ALA5043874 | ||||||
| 8. | ALA5078260 | [64Cu]Cu-DOTA-TATE | SUV | = | 2.4 | ALA5043872 | ||||||
| 9. | ALA5078260 | [64Cu]Cu-DOTA-TATE | Drug uptake | = | 6.5 | ALA5043871 | ||||||
| 10. | ALA5078260 | [64Cu]Cu-DOTA-TATE | t1/2 | 0 | ALA5043869 | Not Determined | ||||||
| 11. | ALA5078260 | [64Cu]Cu-DOTA-TATE | t1/2 | > | 24 | hr | ALA5043868 | hr | ||||
| 12. | ALA5078260 | [64Cu]Cu-DOTA-TATE | Bmax | = | 779 | fmol/mg | ALA5043867 | fmol/mg | Mus musculus | |||
| 13. | ALA5078260 | [64Cu]Cu-DOTA-TATE | Kd | = | 1.55 | nM | ALA5043866 | 8.81 | nM | Mus musculus | ||
| 14. | ALA5078260 | [64Cu]Cu-DOTA-TATE | Kd | 0 | ALA5043865 | Not Determined | Homo sapiens | |||||
| 15. | ALA5078260 | [64Cu]Cu-DOTA-TATE | logD | = | -3.41 | ALA5043864 | ||||||
| 16. | ALA5078260 | [64Cu]Cu-DOTA-TATE | PB | < | 30 | % | ALA5043863 | % | Homo sapiens | |||
| 17. | ALA5078260 | [64Cu]Cu-DOTA-TATE | PPB | = | 46 | % | ALA5043862 | % |
The page will load shortly, Thanks for your patience!